• No results found

University of Groningen Novel heart failure biomarkers Du, Weijie

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Novel heart failure biomarkers Du, Weijie"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Novel heart failure biomarkers

Du, Weijie

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Du, W. (2019). Novel heart failure biomarkers: Physiological studies to understand their complexity.

University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Novel Heart Failure Biomarkers:

Physiological studies to understand their complexity

(3)

Financial support by the Dutch Heart Foundation for the publication of this thesis is

gratefully acknowledged.

Financial support by the Groningen University institute for Drug Exploration (Guide) and the

Rijksuniversiteit Groningen for publication of this thesis is gratefully acknowledged.

Financial support by Natural Science Foundation of China for publication of this thesis is

gratefully acknowledged.

Novel Heart Failure Biomarkers: Physiological studies to understand their complexity © copyright 2019 Weijie Du

All rights reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, without permission of the author.

ISBN: 978-94-034-1386-0; printed version ISBN: 978-94-034-1387-7; electronic version Layout: Weijie Du

(4)

Novel Heart Failure Biomarkers

Physiological studies to understand their complexity

PhD thesis

to obtain the degree of PhD at the

University of Groningen

on the authority of the

Rector Magnificus prof. E. Sterken

and in accordance with

the decision by the College of Deans.

This thesis will be defended in public on

Monday 11 February 2019 at 12.45 hours

by

Weijie Du

born on 12 August 1988

in Neimongol, China

(5)

Supervisor:

Prof. dr. R.A. de Boer

Co-supervisor:

Dr. H.H.W. Sillje

Assessment Committee

Prof. dr. A.A. Voors

Prof. dr. P. Heeringa

Prof. dr. B. Schroen

(6)

Paranymphs:

Salva Yurista

Peijia Jiang

(7)
(8)

TABLE OF CONTENTS

Chapter 1

Introduction

9

Chapter 2

Novel heart failure biomarkers: why do we fail to

exploit their potential?

21

Chapter 3

MicroRNA-328, a Potential Anti-Fibrotic Target in

Cardiac Interstitial Fibrosis

55

Chapter 4

A novel oral available myeloperoxidase (MPO)

inhibitor delays cardiac remodeling in a pressure

overload mouse model

71

Chapter 5

Plasma levels of heart failure biomarkers are

primarily a reflection of extracardiac production

99

Chapter 6

Tissue plasma-biomarker expression in Ren2

hypertensive heart failure rats

139

Chapter 7

Summary, discussion and future perspectives

159

Samenvatting, discussie en toekomstperspectieven

169

Acknowledgements

177

(9)

Referenties

GERELATEERDE DOCUMENTEN

In particular, we included two models of HF with reduced ejection fraction (HFrEF), namely a transverse aortic constriction and a myocardial infarction model (TAC and MI) and

Plasma biomarkers have the potential to provide information about specific processes (e.g. interstitial/ replacement fibrosis, endothelial dysfunction, and pathological

For instance, in the general population, markers of cardiac stretch (natriuretic peptides) and fibrosis (galectin-3) are higher in women, whereas markers of cardiac injury

These results are in line with a previous study examining associations of cTnT with coronary heart disease (CHD), HF and mortality in the general population (ARIC study) which

we reported that the majority of cardiovascular biomarkers (except UACR) were more strongly associated with HFrEF than HFpEF (23). We now show that these findings are generally

However, minor sex-related differences in predictive value of individual biomarkers were observed: cTns and urinary-albumin-to-creatinine ratio (UACR) improved HF risk prediction

1) Fibro-inflammatoire mechanismen zijn sterk gelinkt aan obesitas, diabetes type 2 en hartfalen. Nieuwe therapeutische interventies gericht op deze mechanismen, hoewel ze

Although baseline biomarker levels differ between men and women, equal increases in biomarker levels are associated with similar increases in the risk of heart failure in both